ABSTRACT
INTRODUCTION: Recently, studies on behavioral tic suppression techniques have gained popularity as opposed to pharmacological alternatives that often have potentially dangerous side effects. Differential Reinforcement of Other Behaviors therapy (DRO) is one such behavioral technique whose efficacy in tic suppression has been experimentally demonstrated albeit in studies with very few patients, and lacking statistical power. Here, we conducted a meta-analysis of these studies to improve their overall power and explore whether DRO intervention is really effective for tic suppression. MATERIALS AND METHODS: PubMed, Embase, PsycINFO, and Cochrane Library were searched from inception to August 30, 2023. Only original interventional studies that examined the efficacy of DRO for tic suppression were included. RESULTS: A total of 8 no control interventional studies involving 79 children with tic disorders were recruited. Most of the children had moderate tic severity. The pooled mean Yale Global Tic Severity Scale (YGTSS) score was 24.64 (95% CI: 21.99 - 30.12, p = < 0.00001, I2 = 87%). In terms of efficacy of the DRO technique for tic suppression, the results showed that DRO was effective in reducing tic frequency among the children. The pooled standardized mean difference (SMD) was -10.25 (95% CI: -14.71 - -5.79, p = < 0.00001) with I2 = 94%. CONCLUSION: In conclusion, this study revealed that DRO is potentially an effective tic suppression technique for temporarily managing tic disorder. It also showed that DRO could be employed for both moderate and severe tic disorders. However, the technique bears crucial limitations that limit its implementation outside of experimental settings. More studies are needed to address these limitations and improve its applicability in the real world.
Subject(s)
Tic Disorders , Tics , Child , Humans , Tics/therapy , Tic Disorders/drug therapyABSTRACT
BACKGROUND: Clinical trials of new drugs for tic disorders (TD) often fail to yield positive results. Placebo and nocebo responses play a vital role in interpreting the outcomes of randomized controlled trials (RCTs), yet these responses in RCTs of TD remain unexplored. OBJECTIVE: The aim was to assess the magnitude of placebo and nocebo responses in RCTs of pharmacological interventions for TD and identify influencing factors. METHODS: A systematic search of the Embase, Medline, Cochrane Central Register of Controlled Trials, and PsycINFO databases was conducted. Eligible studies were RCTs that compared active pharmacological agents with placebos. Placebo response was defined as the change from baseline in TD symptom severity in the placebo group, and nocebo response as the proportion experiencing adverse events (AEs) in this group. Subgroup analysis and meta-regression were performed to explore modifying factors. RESULTS: Twenty-four trials involving 2222 participants were included in this study. A substantial placebo response in TD symptom severity was identified, with a pooled effect size of -0.79 (95% confidence interval [CI] -0.99 to -0.59; I2 = 67%). Forty-four percent (95% CI 27% to 63%; I2 = 92%) of patients experienced AEs while taking inert pills. Sample size, study design, and randomization ratio were correlated with changes in placebo and nocebo responses. CONCLUSION: There were considerable placebo and nocebo responses in TD clinical trials. These results are of great relevance for the design of future trials and for clinical practice in TD. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration ID CRD42023388397. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Subject(s)
Nocebo Effect , Placebo Effect , Tic Disorders , Humans , Randomized Controlled Trials as Topic , Tic Disorders/drug therapyABSTRACT
This study aims to comprehensively evaluate the clinical value of Shaoma Zhijing Granules(SZG), Changma Xifeng Tablets(CXT), and Jiuwei Xifeng Granules(JXG) in the treatment of children with tic disorder with the method of rapid health technology assessment(RHTA), which is expected to serve as a reference for medical and health decision-making and clinical rational use of drugs in children. To be specific, relevant articles were retrieved from eight databases and three clinical trial registry platforms. After the quality evaluation, rapid assessment was carried out from the dimensions of disease burden and unmet needs, technical characteristics, safety, efficacy and economy, and the results were analyzed and presented descriptively. A total of 22 articles(1 in English, 21 in Chinese) were screened out: 18 randomized controlled trials(RCTs) and 4 clinical controlled trials(CCTs). Among them, 5 were about the SZG(all RCTs) and 9 were on CXT(6 RCTs and 3 CCTs). The rest 8 focused on JXG(7 RCTs and 1 CCT). Moreover, the overall risk of bias for 94.40% RCTs was evaluated as "some concerns" and only one(5.60%) had high risk of bias. In terms of quality, the 4 CCTs scored 5-6 points(<7 points), suggesting low quality. SZG alone or in combination with tiapride has obvious advantages in improving traditional Chinese medicine syndromes and tic symptoms compared with tiapride alone, with the average daily cost of CNY 79.44-119.16. Compared with conventional western medicine or placebo, CXT alone or in combination with conventional western medicine can improve the total effective rate and alleviate tic symptoms, and the average daily cost is CNY 22.50-67.50. JXG alone or in combination with conventional western medicine can effectively relieve tic symptoms compared with conventio-nal western medicine or placebo, with the average daily cost of CNY 82.42-164.85. The adverse events related to the three Chinese patent medicines mainly occurred in the digestive, respiratory, and nervous systems, all of which were mild. In general, SZG, CXT, and JXG are effective for children with tic disorder. They have been approved to be used in this field, of which SZG was approved in 2019, with the most up-to-date research evidence and high-quality RCT in Q1 journals. However, the comparative analysis of the three was affected by many factors, which should be further clarified. Based on the large sample data available in multiple dimensions, a comprehensive comparative evaluation of the three Chinese patent medicines should be carried out, thereby highlighting the advantages and disadvantages of them and serving a reference for rational clinical use and drug supervision.
Subject(s)
Humans , Child , Drugs, Chinese Herbal/therapeutic use , Nonprescription Drugs/therapeutic use , Technology Assessment, Biomedical , Tiapride Hydrochloride/therapeutic use , Tics/drug therapy , Tic Disorders/drug therapy , Medicine, Chinese TraditionalABSTRACT
No disponible
Subject(s)
Aged , Humans , Male , Tic Disorders/complications , Tic Disorders/diagnosis , Tic Disorders/drug therapy , Tic Disorders/physiopathology , Trigeminal Neuralgia/complications , Trigeminal Neuralgia/diagnosis , Trigeminal Neuralgia/drug therapy , Trigeminal Neuralgia/physiopathology , Anticonvulsants/therapeutic use , Carbamazepine/analogs & derivatives , Carbamazepine/therapeutic use , Headache/etiology , SyndromeSubject(s)
Child , Humans , Autoimmune Diseases of the Nervous System/immunology , Obsessive-Compulsive Disorder/immunology , Streptococcal Infections/immunology , Autoimmune Diseases of the Nervous System/microbiology , Basal Ganglia/immunology , Blotting, Western , Obsessive-Compulsive Disorder/microbiology , Streptococcal Infections/complications , Streptococcus pyogenes , Tic Disorders/drug therapy , Tic Disorders/microbiologySubject(s)
Child , Humans , Autoimmune Diseases of the Nervous System/drug therapy , Obsessive-Compulsive Disorder/drug therapy , Streptococcal Infections/drug therapy , Tic Disorders/drug therapy , Autoimmune Diseases of the Nervous System/diagnosis , Autoimmune Diseases of the Nervous System/microbiology , Obsessive-Compulsive Disorder/microbiology , Pharyngitis/microbiology , Streptococcal Infections/complications , Streptococcus pyogenes/isolation & purification , Tic Disorders/microbiologyABSTRACT
El Síndrome de Tourette es un trastorno frecuente en niños y adolescentes, y cada vez más reconocido en nuestro medio. Tiene una asociación establecida con otras comorbilidades como el síndrome de déficit atencional y el trastorno obsesivo compulsivo. En esta revisión se analizan nuevos avances en la comprensión de su fisiopatología y las nuevas alternativas terapéuticas disponibles.
Subject(s)
Humans , Tourette Syndrome/physiopathology , Tourette Syndrome/therapy , Tics/classification , Tic Disorders/drug therapy , Tic Disorders/therapyABSTRACT
Muchos niños presentan en algún momento de su vida movimientos involuntarios o tics, los cuales preocupan al paciente y a su familia. La gran mayoría de ellos es de carácter transitorio y se puede manejar por el pediatra. Sin embargo, los tics del síndrome de Gilles de la Tourette son complejos y a veces socialmente invalidantes, por lo que es necesario conocer su sintomatología y posibilidades terapéuticas por el especialista